← Evidence map

ArticleThoracic cancer2020

Osimertinib for compound EGFR exon 19 deletion/T790M mutated lung squamous cell carcinoma.

MuYun Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32667739